Telehealth prescribing has revolutionized behavioral healthcare by increasing access to essential medications. This has led to a significant rise in the proportion of Medicaid beneficiaries receiving buprenorphine treatment through telehealth. While the Drug Enforcement Administration has extended virtual prescribing flexibilities until 2025, the lack of permanent regulations creates uncertainty. The continuity of care for patients receiving controlled substances through telehealth is at risk. Establishing permanent frameworks that balance accessibility and safety is necessary. Challenges include patient safety concerns, administrative pressures for healthcare providers, and limited access for underserved communities. Collaborative efforts between providers, patients, and policymakers are crucial to ensure continued access to essential medications through telehealth.
Source link
Navigating Virtual Prescribing Policy Changes in 2025
